Jeremiah Alt
Otolaryngology · Portland, ORNPI 1598968380
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,784 of the $88,599 with a category attached, or 69.7%. 11 manufacturers reported payments, led by GSK at 39.8% of the total. 2025 is the largest year on record at $40,585, more than ten times the $202 reported in 2019. Among otolaryngology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $720.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$35K
- Optinose US, Inc.$19K
- Regeneron Healthcare Solutions, Inc.$16K
- Medtronic$15K
- Sanofi$3K
- Stryker$701
- plus $380 from 5 others
Across 11 payments — averaging $5812.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$41K
- Sanofi US Services Inc.$12K
- GSK$6K
- AstraZeneca$5K
What the payments were for
- Consulting fees$61,78470%
- Speaking & faculty fees$17,80020%
- Travel & lodging$4,9696%
- Food & beverage$4,0475%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 35 | $35,292 |
| Optinose US, Inc. | 15 | $18,552 |
| Regeneron Healthcare Solutions, Inc. | 13 | $15,953 |
| Medtronic(2 entities) | 40 | $15,029 |
| Sanofi | 5 | $2,692 |
| Stryker | 9 | $701 |
| Acclarent, Inc | 2 | $251 |
| AstraZeneca | 1 | $48 |
| Johnson & Johnson | 1 | $29 |
| Aerin Medical Inc. | 1 | $28 |
| KARL Storz Endoscopy-america | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$28,813
- Xhance$18,450
- DUPIXENT$15,548
- STRAIGHTSHOT$7,536
- FUSION$4,867
- PROPEL$277
- TruDi Nav Cable$251
- SCOPIS ENT$163
- STEALTHSTATION S8 PLATFORM$156
- HEMOPORE$149
- N/A$131
- CORE$102
- SONOPET IQ$102
- SPETZLER-MALIS$102
- 1788$102
- UNIVERSAL NEURO 2$102
How this compares
$88,599 in reported general payments places this provider in the 95th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 35 | $1,163 |
| Fluticasone Propionate | 36 | $427 |
| Montelukast Sodium | 36 | $355 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $174 |
| Doxycycline Hyclate | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Portland
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Daniel ClayburghPortland$7K
- Timothy HullarPortland$7K
- Paul FlintPortland$7K
- Justin HallPortland$4K
- Katie MelderPortland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.